Micro complement fixation assay for type-specific group A streptococcal antibody

Area of Science:

• Immunology
• Microbiology
• Serology

Background:

• Group A streptococcal infections remain a significant public health concern.
• Accurate measurement of type-specific antibodies is crucial for understanding immunity and vaccine development.
• Existing serological assays for anti-M antibodies have limitations, including cross-reactivity.

Purpose of the Study:

• To develop and validate a micro complement fixation assay for measuring type-specific anti-M antibodies.
• To compare the performance of the micro complement fixation assay with the Lancefield bactericidal assay and passive hemagglutination.
• To evaluate the potential of the micro complement fixation assay as a substitute for the bactericidal test.

Main Methods:

• A micro complement fixation assay was developed using sera from hyperimmunized rabbits and humans.
• Sera were tested against homologous M proteins (serotypes 1, 3, 6, 12, 14).
• Complement fixation results were compared with those from Lancefield bactericidal and passive hemagglutination assays.
• Serological activity was analyzed using Sephadex G-200 gel filtration to isolate 7S globulin fractions.

Main Results:

• The micro complement fixation assay demonstrated high type-specificity, fixing complement only with homologous M proteins.
• Results from the complement fixation assay closely correlated with the Lancefield bactericidal assay.
• The assay did not exhibit the cross-reactions often observed with passive hemagglutination.
• The serological activity was localized to the 7S globulin fraction.

Conclusions:

• The micro complement fixation assay is a specific and reliable method for quantifying type-specific anti-M antibodies.
• This assay offers a promising alternative to the bactericidal test for assessing immunity to group A streptococci.
• Further evaluation of this micro complement fixation assay is warranted for clinical and research applications.